Integra LifeSciences Holdings Corp.
IART
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 3 days ago • IART
Should You Continue to Hold Integra Stock in Your Portfolio Now?
Zacks Investment Research • 17 days ago • IART
Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up
Zacks Investment Research • 20 days ago • IART
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term
Seeking Alpha • 21 days ago • IART
Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript
Zacks Investment Research • 21 days ago • IART
Integra (IART) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.